Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 154,095 | 50,247 | 2,726 | 0 | 0 |
| Marketable Securities | 11,583 | N/A | N/A | 0 | 0 |
| Receivables | 871 | 946 | 1,014 | 0 | 0 |
| TOTAL | $168,158 | $52,072 | $4,595 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 7,154 | 7,676 | 8,280 | N/A | N/A |
| Other Non-Current Assets | 157 | 158 | 197 | 0 | 0 |
| TOTAL | $7,310 | $7,833 | $8,477 | $N/A | $N/A |
| Total Assets | $175,468 | $59,906 | $13,072 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,747 | 3,823 | 4,444 | 0 | 0 |
| Accounts payable and accrued liabilities | 10,059 | 11,470 | 7,024 | 0 | 0 |
| TOTAL | $19,789 | $27,327 | $28,159 | $0 | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 12 | 439 | 0 | 0 |
| Deferred Revenues | 6,984 | 12,034 | 16,691 | N/A | N/A |
| Other Non-Current Liabilities | 2,518 | 2,497 | 2,550 | 0 | 0 |
| TOTAL | $2,760 | $3,001 | $3,730 | $N/A | $N/A |
| Total Liabilities | $22,548 | $30,328 | $31,889 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 24,918 | 23,678 | N/A | N/A | N/A |
| Common Shares | 24 | 1 | 1 | 0 | 0 |
| Retained earnings | -306,496 | -291,909 | -277,225 | 0 | 0 |
| Other shareholders' equity | -1 | 158,140 | 80,824 | 0 | 0 |
| TOTAL | $152,920 | $29,577 | $-18,817 | $0 | $0 |
| Total Liabilities And Equity | $175,468 | $59,906 | $13,072 | $0 | $0 |